A subscription to JoVE is required to view this content. Sign in or start your free trial.
This protocol illustrates an in vitro endothelial cell transcytosis assay as a model to evaluate inner blood-retinal barrier permeability by measuring the ability of human retinal microvascular endothelial cells to transport horseradish peroxidase across cells in caveolae-mediated transcellular transport processes.
Dysfunction of the blood-retinal barrier (BRB) contributes to the pathophysiology of several vascular eye diseases, often resulting in retinal edema and subsequent vision loss. The inner blood-retinal barrier (iBRB) is mainly composed of retinal vascular endothelium with low permeability under physiological conditions. This feature of low permeability is tightly regulated and maintained by low rates of paracellular transport between adjacent retinal microvascular endothelial cells, as well as transcellular transport (transcytosis) through them. The assessment of retinal transcellular barrier permeability may provide fundamental insights into iBRB integrity in health and disease. In this study, we describe an endothelial cell (EC) transcytosis assay, as an in vitro model for evaluating iBRB permeability, using human retinal microvascular endothelial cells (HRMECs). This assay assesses the ability of HRMECs to transport transferrin and horseradish peroxidase (HRP) in receptor- and caveolae-mediated transcellular transport processes, respectively. Fully confluent HRMECs cultured on porous membrane were incubated with fluorescent-tagged transferrin (clathrin-dependent transcytosis) or HRP (caveolae-mediated transcytosis) to measure the levels of transferrin or HRP transferred to the bottom chamber, indicative of transcytosis levels across the EC monolayer. Wnt signaling, a known pathway regulating iBRB, was modulated to demonstrate the caveolae-mediated HRP-based transcytosis assay method. The EC transcytosis assay described here may provide a useful tool for investigating the molecular regulators of EC permeability and iBRB integrity in vascular pathologies and for screening drug delivery systems.
The human retina is one of the highest energy-demanding tissues in the body. Proper functioning of the neural retina requires an efficient supply of oxygen and nutrients along with a restricted flux of other potentially harmful molecules to protect the retinal environment, which is mediated via the blood-retinal barrier (BRB)1. Similar to the blood-brain barrier (BBB) in the central nervous system, the BRB acts as a selective barrier in the eye, regulating the movement of ions, water, amino acids, and sugar in and out of the retina. BRB also maintains retinal homeostasis and its immune privilege by preventing exposure to circulatory factors suc....
All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at Boston Children's Hospital for the generation of light microscopy and EM images (Figure 3). Protocols for the in vivo studies can be obtained from Wang et al.24. All experiments involving human retinal microvascular endothelial cells (HRMECs) were approved by the Institutional Biosafety Committee (IBC) at Boston Children's Hospital.
EM images of retinal vascular endothelium show transcytotic vesicular transport and caveolar vesicles in endothelial cells in vivo.
EC transcytosis can be visualized in vivo within retinal cross-sections with dark brown precipitate reflecting HRP-containing blood vessels under a light microscope (Figure 3A) and as electron-dense precipitate indicative of HRP-containing transcytotic vesicles (Figur.......
BRB plays an essential role in retinal health and disease. In vitro techniques assessing vascular permeability have proven to be crucial tools in studies concerning barrier (BRB/BBB) development and function. The procedure described here could be utilized to study the molecular mechanisms underlying EC transcytosis or evaluate related molecular modulators affecting BRB permeability. In vitro EC transcytosis assays have multiple advantages over in vivo assays or techniques used for evaluating va.......
This work was supported by NIH grants (R01 EY028100, EY024963, and EY031765) to JC. ZW was supported by a Knights Templar Eye Foundation Career Starter Grant.
....Name | Company | Catalog Number | Comments |
Biological Safety Cabinet | Thermo Electron Corporation, Thermo Fisher Scientific | 1286 | |
Cell culture petridish | Nest Biotechnology | 704001 | |
Centrifuge | Eppendorf | 5702 | |
Centrifuge tubes (15 mL) | Corning Inc. | 352097 | |
Centrifuge tubes (50 mL) | Denville Scientific Inc. | C1062-P | |
Cyanine 3-human Transferrin | Jackson ImmunoResearch | AB_2337082 | |
Endothelial Cell Basal Medium-2 (EBM-2) | Lonza Bioscience | CC-3156 | |
Endothelial Cell Growth Medium-2 (EGM-2) SingleQuots supplements | Lonza Bioscience | CC-4176 | |
EVOM Millicell Electrical Resistance System-2 (ERS-2) | Millipore | MERS00002 | |
Fetal Bovine Serum (FBS) | Lonza Bioscience | CC-4102B | |
Gelatin | Sigma-Aldrich | G7765 | |
Hemocytometer (2-chip) | Bulldog Bio | DHC-N002 | |
Horseradish Peroxidase (HRP) | Sigma-Aldrich | P8250 | |
Human retinal microvascular endothelial cells (HRMEC) | Cell Systems | ACBRI 181 | |
Incubator | Thermo Electron Corporation, Thermo Fisher Scientific | 3110 | |
L cells (for Control-conditioned medium) | ATCC | CRL-2648 | |
L Wnt-3A cells (for Wnt3A-conditioned medium) | ATCC | CRL-2647 | |
Light microscope | Leica | DMi1 | |
Multimode Plate Reader | EnSight, PerkinElmer | ||
Phosphate-buffered saline (PBS) buffer (1x) | GIBCO | 10010-023 | |
QuantaBlu Fluorogenic Peroxidase Substrate kit | Thermo Fisher Scientific | 15169 | |
Recombinant human Norrin (rhNorrin) | R&D Systems | 3014-NR | |
Recombinant human Vascular endothelial growth factor (rhVEGF) | R&D Systems | 293-VE | |
Syringe filter (0.22 µm) | Millipore | SLGP033RS | |
Transwell inserts (6.5 mm transwell, 0.4 µm pore polyester membrane insert) | Corning Inc. | CLS3470-48EA | |
Trypsin-EDTA (0.25%) (1x) | GIBCO | 25-200-072 | |
Water bath | Precision, Thermo Fisher Scientific | 51221060 | |
XAV939 (Wnt/β-catenin Inhibitor) | Selleckchem | S1180 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved